Skip to main content

Table 1 Antimicrobial susceptibility, production of β-lactamases, and pulsotype of the 69 isolates of A. baumannii analyzed in this study.

From: Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii

    

MIC Method Phoenix (μg/ml)b

   

Number of isolates

Hospital

Sample Source

Ward/unita

TE

A/S

CI

AK

GM

PP

PT

AT

CZ

CP

IP

MP

MIC IP (μg/ml)

β-lactamases

Pulsotype

2

S. Matteo

Blood

Medicine

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>32

>16

≤1

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL

6

S. Matteo

Sputum

Medicine

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>32

>16

≤1

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL

2

S. Matteo

Urine

Medicine

4

/

>2

>32

>8

>64

>64/4

>16

>16

/

2

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL

6

S. Matteo

Soft tissue swab

Medicine

4

8/4

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL, SMAL 2,

3

S. Matteo

Bronchoaspirate

Medicine

/

8/4

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL, SMAL 3

3

S. Matteo

Urine

Surgery

4

/

>2

>32

>8

>64

>64/4

>16

>16

/

2

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL

8

S. Matteo

Wound swab

Surgery

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL

8

S. Matteo

Blood

Surgery

/

/

>2

>32

>8

>64

>64/4

>16

>16

/

2

≤1

0.5-1.0

AmpC, OXA-90, OXA-10

SMAL, SMAL 1

1

S. Matteo

Pus

Surgery

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Sputum

Surgery

/

4/2

>2

>32

>8

>64

64/4

>16

>16

>16

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Soft tissue swab

LTCU

≤2

/

>2

>32

>8

>64

64/4

>16

>16

>16

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Sputum

LTCU

/

/

>2

>32

>8

>64

64/4

>16

>16

>16

2

≤1

1

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Blood

LTCU

/

/

>2

32

>8

>64

64/4

>16

>16

>16

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

2

S. Matteo

Soft tissue swab

Dermatology

≤2

/

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

0.5-1

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Pus

Dermatology

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤

1

AmpC, OXA-90, OXA-10

SMAL

2

S. Matteo

Wound swab

Ambulatory

/

/

>2

>32

>8

>64

>64/4

>16

>16

>16

4

2

2

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Urine

Ambulatory

≤2

/

>2

>32

>8

>64

>64/4

>16

>16

/

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

2

S. Matteo

Wound swab

Urology

≤2

/

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

0.5

AmpC, OXA-90, OXA-10

SMAL

2

S. Matteo

Urine

Nephrology

/

/

>2

>32

>16

>64

>64/4

>16

>16

/

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

1

S. Matteo

Blood

Haematology

8

/

>2

>32

>8

>64

>64/4

>16

>16

16

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

1

S. Maugeri

Bronchoaspirate

PRU

8

/

>2

>32

>8

>64

>64/4

>16

>16

/

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

7

S. Maugeri

Urine

NRU

/

/

>2

>32

>8

>64

64/4

>16

>16

/

≤1

≤1

1

AmpC, OXA-90, OXA-10

SMAL

2

S. Maugeri

Skin swab

NRU

/

8/4

>2

>32

>8

>64

>64/4

>16

>16

>16

≤1

≤1

0.5

AmpC, OXA-90, OXA-10

SMAL

1

S. Maugeri

Bronchoaspirate

NRU

≤2

/

>2

>32

>8

>64

64/4

>16

>32

/

≤1

≤1

0.5-1

AmpC, OXA-90, OXA-10

SMAL

1

S. Maugeri

Urine

ORU

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>32

/

≤1

≤1

0.5

AmpC, OXA-90, OXA-10

SMAL

1

S. Maugeri

Skin swab

ORU

≤2

8/4

>2

>32

>8

>64

64/4

>16

>32

/

≤1

≤1

0.5

AmpC, OXA-90, OXA-10

SMAL

2

S. Maugeri

Urine

FRU

≤2

8/4

>2

>32

>8

>64

>64/4

>16

>32

>16

≤1

≤1

0.5

AmpC, OXA-90, OXA-10

SMAL

  1. a PRU, pulmonary rehabilitation unit; NRU, neurological rehabilitation unit; ORU, oncological rehabilitation unit. b TE, tetracicline; A/S, ampicillin/sulbactam; CI, ciprofloxacin; AK, amikacin; GM, gentamicin; PP, piperacillin; PT, piperacillin/tazobactam; AT, aztreonam; CZ, ceftazidime; CP, cefepime; IP, imipenem; MP, meropenem. Ditto marks indicate that the β-lactamase pattern was identical for all the strains tested.